ALMOTRIPTAN MALATE PDF

In addition, it is expected that almotriptan malate (AXERT®) is generally Trial to Evaluate the Efficacy of Almotriptan Malate (AXERT®) Milligram. Almotriptan is a headache medicine that narrows blood vessels around the brain. Almotriptan also reduces substances in the body that can. Almotriptan is a triptan drug for the treatment of migraine headaches. Almotriptan Malate, Tablet, coated, mg/1, Oral, Patriot Pharmaceuticals,

Author: Felrajas Aranos
Country: Saudi Arabia
Language: English (Spanish)
Genre: Politics
Published (Last): 25 August 2013
Pages: 286
PDF File Size: 13.52 Mb
ePub File Size: 20.18 Mb
ISBN: 461-5-39249-127-1
Downloads: 86773
Price: Free* [*Free Regsitration Required]
Uploader: Arall

Bacitracin Bacitracin may decrease the excretion rate of Almotriptan which could result in a higher serum level.

Things to note about Axert Axert tablets are taken by mouth.

Axert® (almotriptan malate)

Delorazepam The risk or severity of adverse effects can be increased when Almotriptan is combined with Delorazepam. The safety and efficacy of almotriptan have not been established in neonates, infants, or children less than 12 years of age. Ceftizoxime Ceftizoxime may decrease the a,motriptan rate of Almotriptan which could result in a higher serum level.

They should be used cautiously in conjunction with meperidine, as meperidine blocks the neuronal reuptake of serotonin. Enalapril The metabolism of Almotriptan can be decreased when combined with Enalapril. Almotriptan has similar efficacy as a standard dose of sumatriptananother triptan drug, and fewer adverse effects.

Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Almotriptan.

Benorilate Benorilate may decrease the excretion rate of Almotriptan which could result in a higher serum level. Atracurium The risk or severity of adverse effects can be increased when Almotriptan is combined with Atracurium.

Major Because of the potential risk and severity of serotonin syndrome, caution should be observed when administering a selective serotonin norepinephrine reuptake inhibitor SNRI like milnacipran with other drugs that have serotonergic properties such as serotonin-receptor agonists e. Major Ritonavir may increase the systemic exposure of almotriptan. Galantamine Galantamine may decrease the excretion rate of Almotriptan which could result in a higher serum level.

TOP Related Articles  GIGABYTE GA-EP35-DS3L MANUAL PDF

At high doses, amphetamines can increase serotonin release, as well as act as serotonin agonists. Bleomycin Bleomycin may decrease the excretion rate of Almotriptan which could result in a higher serum level. Flupirtine Almotriptan may decrease the excretion rate of Flupirtine which could result in a higher serum level.

Cefamandole Cefamandole may decrease the excretion rate of Almotriptan which could result in a higher serum level. Moderate Use caution if coadministration of telotristat ethyl and almotriptan is necessary, as the systemic exposure of almotriptan may be decreased resulting in reduced efficacy.

Ibutilide Ibutilide may decrease the excretion rate of Almotriptan which could result in a higher serum level. Corifollitropin alfa Almotriptan may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.

Major Erythromycin may increase the systemic exposure of almotriptan. Cilansetron The risk or severity of adverse effects can be increased when Almotriptan is combined with Cilansetron. Atomoxetine The risk or severity of adverse effects can be increased when Atomoxetine is combined with Almotriptan.

Acrivastine Almotriptan may decrease the excretion rate of Acrivastine which could result in a higher serum level.

Darunavir The metabolism of Almotriptan can be decreased when combined with Darunavir. Bromotheophylline Bromotheophylline may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.

Danazol The metabolism of Almotriptan can be decreased when combined with Danazol. Arotinolol Almotriptan may decrease the excretion rate of Arotinolol which could result in a higher serum level.

Diacerein The metabolism of Almotriptan can be decreased when combined with Diacerein. Clemastine The risk or severity of adverse effects can be increased when Clemastine is combined with Almotriptan.

Avoid coadministration in patients with renal or hepatic impairment.

PDR Search

Gefitinib The metabolism of Almotriptan can be decreased when combined with Gefitinib. Remember to always consult your physician or health care provider before starting, stopping, or altering a treatment or health care regimen.

Gedocarnil The risk or severity of adverse effects can be increased when Almotriptan is combined with Gedocarnil.

Clomethiazole The risk or severity of adverse effects can be increased when Almotriptan is combined with Clomethiazole.

TOP Related Articles  ALLEGRO A3977 PDF

Moderate Maprotiline should be used cautiously with drugs that also augment serotonin, like the a,motriptan agonists “triptans” used for the treatment of migraine. People with moderate-to-severe renal dysfunction are recommended to use only half the dose.

Hygromycin Malare Hygromycin B may decrease the excretion rate of Almotriptan which could result in a higher serum level. Clopenthixol The risk or severity of adverse effects can be increased when Almotriptan is combined with Clopenthixol. Certolizumab pegol The metabolism of Almotriptan can be increased when combined with Certolizumab pegol.

If a patient does not respond to almotriptan for the first migraine attack, the diagnosis of migraine should be re-evaluated prior to almotgiptan use of the drug. If concurrent use is necessary, closely monitor the patient, particularly during remifentanil initiation and dosage adjustment.

Almotriptan malate | C21H31N3O7S – PubChem

Amlodipine The metabolism of Almotriptan can be decreased when combined with Amlodipine. Cloranolol The metabolism of Cloranolol can be decreased when combined with Almotriptan.

Amoxicillin Almotriptan may decrease the excretion rate of Amoxicillin which could result in a higher serum level. Halazepam The risk or severity of adverse effects can be increased when Halazepam is combined with Almotriptan. Bufuralol The metabolism of Bufuralol can be decreased when combined with Almotriptan. Estramustine The metabolism of Estramustine can be decreased when combined with Almotriptan. Hydroflumethiazide Hydroflumethiazide may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.

Geneticin Geneticin may decrease the excretion rate of Almotriptan which could result in a higher serum level. Doxapram The risk or severity of hypertension can be increased when Doxapram is combined with Almotriptan. Enzalutamide The metabolism of Almotriptan can be increased when combined almtriptan Enzalutamide.